# Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)

> **NCT03026842** · PHASE4 · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 180 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Daunorubicin, Cytarabine
- **DRUG:** Mitoxantrone, Cytarabine
- **DRUG:** Aclacinomycin, Cytarabine

## Key facts

- **NCT ID:** NCT03026842
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2017-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026842, "Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03026842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*